Dysgeusia News and Research

RSS

Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults

Paxlovid (nirmatrelvir-ritonavir) does not reduce hospital admissions or deaths in vaccinated adults at higher risk of severe COVID-19, despite helping them recover faster, according to results from two national trials published today in the New England Journal of Medicine.

22 Apr 2026

Scientists identify common symptom patterns in post-COVID-19 vaccination syndrome

A registry study across 14 Japanese clinics analyzed 179 cases of post-COVID-19 vaccination syndrome (PCVS) and identified 493 adverse events affecting multiple organ systems. Most symptoms appeared within 90 days, but some occurred much later, highlighting the need for continued vaccine safety monitoring and better clinical frameworks for persistent post-vaccination symptoms.

16 Mar 2026

Analyzing the role of smoking in viral recovery

COVID-19 brought about lasting changes that are still being felt today in the post-pandemic era, with one being the unprecedented side effect known as Long COVID.

27 Jan 2026

Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell composition with low adverse events.

30 Jan 2025

Long COVID affects 38% of emergency patients with persistent symptoms

Researchers found that post-COVID-19 condition (PCC) symptoms persist in a significant number of both SARS-CoV-2 positive and negative emergency department patients, highlighting the non-specific nature of the WHO’s PCC criteria.

1 Oct 2024

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

A study in The New England Journal of Medicine evaluates the combination of nirmatrelvir and ritonavir against COVID-19, finding it does not significantly reduce symptom duration in vaccinated or unvaccinated adult outpatients.

8 Apr 2024

Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Researchers investigated insomnia prevalence and its association with anxiety and depression in the non-hospitalized COVID-19-recovered community.

7 Feb 2024

Scientists discover key brain cells affected by COVID-19

A recent Cell Stem Cell study investigated whether SARS-CoV-2 infection leads to dopaminergic neuron senescence.

22 Jan 2024

Study finds evidence of SARS-CoV-2 exposure in many patients with postviral syndrome

Researchers investigated immunologic and clinical findings indicative of SARS-CoV-2 exposure among individuals with postviral syndrome.

29 Aug 2023

Does COVID-19 increase the risk of future gastrointestinal disorders?

Scientists review existing literature to examine the association between acute COVID-19 and the incidence of gastrointestinal symptoms.

2 Aug 2023

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

31 Jul 2023

Investigating the role of T-cell immunity in long COVID

Researchers investigates the persistence of symptoms and the immune response in patients recovering from COVID-19.

13 Jul 2023

Substance P neuropeptides' role in post-COVID-19 conditions suggested in recent study

Scientists review available evidence on the association between post-COVID-19 conditions and tachykinins.

15 Jun 2023

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

In a recent study published in the journal Molecular & Cellular Proteomics, researchers analyzed the proteins in cerebrospinal fluid (CSF) samples obtained from African green monkeys and rhesus macaques infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 to understand the neurological manifestations of coronavirus disease 2019 (COVID-19).

9 Apr 2023

Dysgeusia News and Research

Paxlovid speeds recovery but does not reduce severe COVID outcomes in vaccinated adults

Scientists identify common symptom patterns in post-COVID-19 vaccination syndrome

Analyzing the role of smoking in viral recovery

Cancer-fighting virus T-VEC helps shrink tough-to-treat skin tumors

Long COVID affects 38% of emergency patients with persistent symptoms

Nirmatrelvir fails to shorten COVID-19 symptoms in latest trial

Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Scientists discover key brain cells affected by COVID-19

Study finds evidence of SARS-CoV-2 exposure in many patients with postviral syndrome

Does COVID-19 increase the risk of future gastrointestinal disorders?

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Investigating the role of T-cell immunity in long COVID

Substance P neuropeptides' role in post-COVID-19 conditions suggested in recent study

Study suggests potential therapeutic targets for COVID-19-related neurological pathologies

Biomarkers that can predict long COVID symptoms

Does COVID-19 accelerate the worsening of clinical disabilities in multiple sclerosis patients?

Over 50% of cancer patients report long COVID symptoms after recovering from COVID-19

Large study on post-COVID dysosmia and dysgeusia

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

What is the long-term cognitive impact of COVID-19, and what are its predictors?

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News